At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
532nm KTP +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Controlled, Open-Label Pilot Study of a Novel 532 nm KTP Laser for the Treatment of Fresh Surgical Scars.
In Brief
A clinical study evaluating 532nm KTP and 595nm PDL for Scar and 4 related conditions. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of the 532nm potassium titanyl phosphate (KTP) laser in comparison with the 595nm pulsed-dye laser (PDL) for the treatment of fresh surgical scars.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScar, Surgical Scar, Cicatrix, Cicatrix, Hypertrophic, Keloid
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedFeb 2013
Primary CompletionMar 2014
Study CompletionDec 2014
TodayJul 2026
First PostedFeb 12, 2013
Enrollment StartFeb 1, 2013
Primary CompletionMar 26, 2014
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 13.4 years ago
Interventions
532nm KTPdevice
up to three treatments of 1/2 of Single scar, or one entire, randomized Bilateral scar.
595nm PDLdevice
up to three treatments of 1/2 of Single scar, or one entire, randomized Bilateral scar.